Palisade Bio (PALI) Short-term Investments (2014 - 2017)
Palisade Bio (PALI) reported Short-term Investments of $5.0 million for Q4 2017, little changed year-over-year from $5.0 million in Q4 2016, and little changed on a QoQ basis from $5.0 million in Q3 2017.
Palisade Bio (PALI) has 4 years of Short-term Investments data on file, last reported at $5.0 million in Q4 2017.
- Quarterly Short-term Investments changed 0.0% year-over-year to $5.0 million in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $5.0 million (changed 0.0% YoY) and the FY2017 annual result came in at $5.0 million, changed 0.0% from the prior year.
- Short-term Investments steadied at $5.0 million in Q4 2017 per PALI's latest filing, from $5.0 million in the prior quarter.
- Across five years, Short-term Investments topped out at $15.0 million in Q1 2015 and bottomed at $5.0 million in Q4 2016.
- The 4-year median for Short-term Investments is $7.5 million (2015), against an average of $9.8 million.
- Peak annual rise in Short-term Investments reached 0.22% in 2015, while the deepest fall reached 66.57% in 2015.
- Tracing PALI's Short-term Investments over 4 years: stood at $15.0 million in 2014, then slumped by 49.91% to $7.5 million in 2015, then sank by 33.49% to $5.0 million in 2016, then changed by 0.0% to $5.0 million in 2017.
- Per Business Quant, the three latest PALI Short-term Investments figures stand at $5.0 million (Q4 2017), $5.0 million (Q3 2017), and $5.0 million (Q2 2017).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 5.00 Mn |
| Sep 30, 2017 | 5.00 Mn |
| Jun 30, 2017 | 5.00 Mn |
| Mar 31, 2017 | 5.00 Mn |
| Dec 31, 2016 | 5.00 Mn |
| Dec 31, 2015 | 7.52 Mn |
| Sep 30, 2015 | 5.02 Mn |
| Jun 30, 2015 | 15.03 Mn |
| Mar 31, 2015 | 15.03 Mn |
| Dec 31, 2014 | 15.01 Mn |
| Sep 30, 2014 | 15.01 Mn |
| Jun 30, 2014 | 15.00 Mn |
| Mar 31, 2014 | 15.00 Mn |